KIR/HLA

Luminița-Ioana Iancu Loga1,2, Ramona Suharoschi3, Florin Ioan Elec2,4

  • 1Department of Cellular and Molecular Biology, Faculty of Medicine, "Iuliu-Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

概括

移植的成功取决于人类白细胞抗原 (HLA) 兼容性和杀手细胞免疫球蛋白样受体 (KIR) 基因. 匹配HLA-DR和考虑KIR基因型可以改善移植的存活率并降低排斥风险.